Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 26 | 2024 | 199 | 9.170 |
Why?
|
| Bilirubin | 6 | 2023 | 224 | 2.520 |
Why?
|
| Neonatal Screening | 6 | 2021 | 182 | 2.510 |
Why?
|
| Liver Transplantation | 14 | 2023 | 1159 | 2.420 |
Why?
|
| Jaundice | 3 | 2023 | 38 | 2.040 |
Why?
|
| Portoenterostomy, Hepatic | 9 | 2023 | 49 | 1.500 |
Why?
|
| Cholestasis | 5 | 2024 | 206 | 1.490 |
Why?
|
| Jaundice, Neonatal | 2 | 2022 | 13 | 1.320 |
Why?
|
| Liver Diseases | 4 | 2022 | 594 | 0.930 |
Why?
|
| Choledocholithiasis | 1 | 2022 | 22 | 0.840 |
Why?
|
| Infant, Newborn | 14 | 2024 | 8540 | 0.760 |
Why?
|
| Infant | 21 | 2024 | 13767 | 0.740 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 187 | 0.720 |
Why?
|
| Fractures, Multiple | 1 | 2019 | 4 | 0.710 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 118 | 0.700 |
Why?
|
| Liver | 8 | 2023 | 2988 | 0.620 |
Why?
|
| Premature Birth | 1 | 2022 | 421 | 0.570 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2017 | 74 | 0.570 |
Why?
|
| Early Diagnosis | 1 | 2018 | 309 | 0.560 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 150 | 0.560 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 464 | 0.540 |
Why?
|
| Retina | 5 | 2008 | 547 | 0.530 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 596 | 0.510 |
Why?
|
| Hypertension, Portal | 3 | 2021 | 128 | 0.470 |
Why?
|
| Hypopituitarism | 1 | 2014 | 32 | 0.460 |
Why?
|
| Matrix Metalloproteinase 7 | 3 | 2024 | 33 | 0.450 |
Why?
|
| Graft Rejection | 1 | 2017 | 846 | 0.430 |
Why?
|
| Glucocorticoids | 2 | 2016 | 630 | 0.420 |
Why?
|
| Platelet Activating Factor | 1 | 2012 | 55 | 0.420 |
Why?
|
| Adenovirus Infections, Human | 2 | 2023 | 55 | 0.420 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2012 | 68 | 0.410 |
Why?
|
| Bile Duct Diseases | 1 | 2012 | 47 | 0.410 |
Why?
|
| Endoscopy, Digestive System | 1 | 2012 | 204 | 0.380 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 256 | 0.360 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2012 | 237 | 0.340 |
Why?
|
| Humans | 42 | 2024 | 269838 | 0.340 |
Why?
|
| Chickens | 2 | 2006 | 527 | 0.310 |
Why?
|
| Thyroid Hormones | 2 | 2008 | 110 | 0.290 |
Why?
|
| End Stage Liver Disease | 2 | 2021 | 186 | 0.270 |
Why?
|
| Bile Acids and Salts | 3 | 2023 | 255 | 0.270 |
Why?
|
| Retroviridae | 1 | 2006 | 323 | 0.250 |
Why?
|
| Child | 15 | 2023 | 30109 | 0.250 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 5113 | 0.240 |
Why?
|
| Live Birth | 2 | 2022 | 59 | 0.240 |
Why?
|
| Biomarkers | 5 | 2024 | 5154 | 0.240 |
Why?
|
| Hepatic Duct, Common | 1 | 2023 | 16 | 0.220 |
Why?
|
| Cholangitis | 1 | 2023 | 49 | 0.210 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2022 | 53 | 0.210 |
Why?
|
| Liver Cirrhosis | 5 | 2023 | 1002 | 0.210 |
Why?
|
| Hyperbilirubinemia | 1 | 2022 | 77 | 0.210 |
Why?
|
| Alagille Syndrome | 1 | 2022 | 46 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2019 | 1509 | 0.200 |
Why?
|
| Adenoviruses, Human | 1 | 2022 | 176 | 0.200 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 90 | 0.200 |
Why?
|
| Hepatitis | 1 | 2022 | 93 | 0.200 |
Why?
|
| RNA Interference | 1 | 2006 | 1409 | 0.190 |
Why?
|
| Epithelium | 1 | 2023 | 722 | 0.180 |
Why?
|
| Abdominal Pain | 1 | 2023 | 374 | 0.180 |
Why?
|
| Gastroenteritis | 1 | 2023 | 310 | 0.180 |
Why?
|
| Respiration, Artificial | 1 | 2023 | 591 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 189 | 0.170 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 182 | 0.170 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 313 | 0.170 |
Why?
|
| Antioxidants | 1 | 2022 | 519 | 0.170 |
Why?
|
| Retrospective Studies | 11 | 2023 | 39453 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 5005 | 0.170 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2019 | 34 | 0.170 |
Why?
|
| Pregnancy | 3 | 2022 | 7819 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2021 | 253 | 0.160 |
Why?
|
| Female | 13 | 2024 | 146823 | 0.160 |
Why?
|
| Reference Values | 1 | 2020 | 1125 | 0.150 |
Why?
|
| Male | 13 | 2024 | 127192 | 0.150 |
Why?
|
| Iodide Peroxidase | 2 | 2008 | 27 | 0.150 |
Why?
|
| Adolescent | 5 | 2023 | 32261 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2021 | 446 | 0.150 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 52 | 0.150 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2016 | 200 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 623 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 483 | 0.140 |
Why?
|
| Spleen | 1 | 2019 | 692 | 0.140 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 30 | 0.140 |
Why?
|
| Prevalence | 2 | 2022 | 3391 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2021 | 582 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2023 | 1820 | 0.130 |
Why?
|
| Critical Care | 1 | 2021 | 796 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 270 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 2049 | 0.120 |
Why?
|
| Ultrasonography | 1 | 2021 | 1925 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 552 | 0.110 |
Why?
|
| Penis | 1 | 2014 | 124 | 0.110 |
Why?
|
| Inflammation | 1 | 2023 | 2553 | 0.110 |
Why?
|
| Pentoxifylline | 1 | 2012 | 35 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2019 | 1016 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 597 | 0.110 |
Why?
|
| Age Factors | 2 | 2020 | 5475 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2023 | 2885 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2018 | 935 | 0.100 |
Why?
|
| Rituximab | 1 | 2017 | 1559 | 0.100 |
Why?
|
| Physical Examination | 1 | 2014 | 302 | 0.100 |
Why?
|
| Chick Embryo | 3 | 2008 | 247 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 875 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2012 | 274 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2012 | 324 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 4543 | 0.090 |
Why?
|
| Young Adult | 2 | 2023 | 22111 | 0.090 |
Why?
|
| Child, Preschool | 5 | 2022 | 16743 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 5091 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7690 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 636 | 0.080 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2008 | 91 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6259 | 0.080 |
Why?
|
| United States | 3 | 2021 | 16290 | 0.080 |
Why?
|
| Adult | 3 | 2023 | 80478 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2008 | 701 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2012 | 823 | 0.070 |
Why?
|
| Time Factors | 3 | 2018 | 13246 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 1103 | 0.070 |
Why?
|
| Aged | 2 | 2023 | 72701 | 0.070 |
Why?
|
| Body Patterning | 1 | 2005 | 214 | 0.060 |
Why?
|
| Parents | 2 | 2023 | 1046 | 0.060 |
Why?
|
| Amphibians | 1 | 2003 | 7 | 0.060 |
Why?
|
| Rodentia | 1 | 2003 | 65 | 0.060 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2003 | 34 | 0.060 |
Why?
|
| Endoglin | 1 | 2022 | 43 | 0.050 |
Why?
|
| Aldehydes | 1 | 2022 | 44 | 0.050 |
Why?
|
| Tretinoin | 1 | 2005 | 636 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2023 | 34218 | 0.050 |
Why?
|
| Risk Factors | 4 | 2023 | 18032 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 322 | 0.050 |
Why?
|
| Viremia | 1 | 2022 | 181 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 6110 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2019 | 2301 | 0.050 |
Why?
|
| Homozygote | 1 | 2023 | 739 | 0.050 |
Why?
|
| Animals | 7 | 2022 | 60906 | 0.050 |
Why?
|
| Genome | 1 | 2004 | 681 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 528 | 0.040 |
Why?
|
| Bile | 1 | 2020 | 83 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 385 | 0.040 |
Why?
|
| Base Sequence | 1 | 2006 | 4912 | 0.040 |
Why?
|
| Cell Division | 1 | 2003 | 2551 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2006 | 6174 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1480 | 0.040 |
Why?
|
| Mice | 4 | 2022 | 35260 | 0.040 |
Why?
|
| Intestinal Atresia | 1 | 2017 | 16 | 0.040 |
Why?
|
| Esophageal Atresia | 1 | 2017 | 49 | 0.040 |
Why?
|
| Exome | 1 | 2023 | 1267 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2023 | 1453 | 0.040 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2017 | 70 | 0.040 |
Why?
|
| Acute Disease | 1 | 2022 | 2472 | 0.040 |
Why?
|
| Carbon Tetrachloride | 1 | 2016 | 24 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 928 | 0.030 |
Why?
|
| Critical Illness | 1 | 2021 | 744 | 0.030 |
Why?
|
| Middle Aged | 1 | 2023 | 89237 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1380 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2016 | 198 | 0.030 |
Why?
|
| Prognosis | 2 | 2023 | 22192 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2015 | 130 | 0.030 |
Why?
|
| Models, Biological | 1 | 2003 | 3250 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 326 | 0.030 |
Why?
|
| Caregivers | 1 | 2021 | 729 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2017 | 644 | 0.030 |
Why?
|
| Colon | 1 | 2017 | 676 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2023 | 6025 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2014 | 275 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 1221 | 0.030 |
Why?
|
| Monocytes | 1 | 2016 | 785 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 551 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2016 | 1221 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2024 | 9448 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 2041 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2214 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9303 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 793 | 0.020 |
Why?
|
| Stem Cells | 2 | 2008 | 1225 | 0.020 |
Why?
|
| Macrophages | 1 | 2016 | 1368 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 2281 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2024 | 13287 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 5120 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 1933 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5620 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 880 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 5780 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2008 | 244 | 0.020 |
Why?
|
| Receptor, EphB3 | 1 | 2005 | 2 | 0.020 |
Why?
|
| Avian Proteins | 1 | 2005 | 26 | 0.020 |
Why?
|
| Receptor, EphB2 | 1 | 2005 | 18 | 0.020 |
Why?
|
| Ephrin-B2 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2005 | 95 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 690 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6881 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 7146 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 107 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 137 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2005 | 368 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 247 | 0.010 |
Why?
|
| Gene Library | 1 | 2004 | 300 | 0.010 |
Why?
|
| Interneurons | 1 | 2004 | 149 | 0.010 |
Why?
|
| Neuroglia | 1 | 2004 | 228 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1060 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 622 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2004 | 1077 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 705 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 742 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1427 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 943 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 1147 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 12095 | 0.010 |
Why?
|
| Computational Biology | 1 | 2004 | 1283 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 4156 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 7739 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 4046 | 0.010 |
Why?
|